A new report published by the Results for Development Institute in the Lancet “has offered governments and donors a glimpse into the future of HIV epidemics â€“ and what it will cost to prevent and treat them. Researchers warn of hard choices ahead and a need for some countries to take more responsibility for their national programmes, IRIN/PlusNews reports. Study authors present their “cheapest” and “ideal” scenarios for HIV funding in the future, according to IRIN/PlusNews.
Mass Media Campaigns’ Effect On Health Behaviors: A Lancet Review examines how campaigns have affected various behaviors, including tobacco use, sexual activity, child survival and others. “Mass media campaigns can directly and indirectly produce positive changes or prevent negative changes in health-related behaviours across large populations,” according to the researchers.…
ABC News on Wednesday announced “a yearlong project to focus attention on the diseases and health conditions that afflict the world’s poorest people,” the Associated Press reports (10/6).
Also In Global Health News: Global Moms Act; NIH, PEPFAR Grants; ARVs In Kenya; Secretary Clinton, Warren Buffett Discuss Global Health
Women’s eNewsÂ Examines Global Moms Act Women’s eNews examines the GlobalÂ Moms Act, which among otherÂ efforts,Â “seeks to make C-sections more available to women in the developing world.” Officially called the “Global Maternal and Newborn Health Outcomes While Maximizing Successes Act” and introduced in the House by Rep.Â Lois Capps (D-Calif.), it “would require…
The global economy has affected HIV/AIDS prevention research, so “scientists and those who fund them are struggling to set priorities among several competing research methods that could slow the spread of the disease, which causes about 2.7 million new infections worldwide a year,” CQ HealthBeat reports. The article looks at the “tension among those searching for effective vaccines and those who are concentrating on other prophylactic methods. With more and more lines of inquiry showing promise, scientists may be victims of their own success.”
Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, “higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world,” the Financial Times reports (Jack, 10/5).
Also In Global Health News: Tentative ARV Approval Under PEPFAR; 50 Years Of Peace Corps; Clean Water In Zimbabwe; Development In Southern Sudan
Matrix Laboratories Recieves Tentative FDA Approval To Provide Generic ARV Under PEPFAR Pharmaceutical company Mylan announced on Tuesday that its “subsidiary Matrix Laboratories Ltd. has received tentative government approval for atazanavir sulfate capsules, an AIDS treatment that will be available in some developing countries,” Pittsburgh Business Times reports.Â “Atazanavir sulfate capsules…
The 57th WHO Eastern Mediterranean regional meeting opened Sunday in Cairo, Egypt, the Emirates News Agency reports (10/2).
“The Obama administration is expected on Tuesday to announce a large increase in its pledge to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and to call for reform of the organization,” the Wall Street Journal reports. “The pledge of $4 billion over the next three fiscal years to the Geneva-based organization comes as governments and donors around the world have slowed increases in spending to combat HIV/AIDS, with weaker economies straining budgets,” the newspaper adds (McKay, 10/5).
Later this month, “[f]our former heads of State and other high-level African leaders who are the champions for a HIV/AIDS-free generation project” will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.